|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.02 USD | -5.46% |
|
-0.39% | +39.43% |
| Market Cap | 3.65B 3.18B 2.96B 2.71B 5.13B 349B 5.2B 34.85B 13.68B 174B 13.72B 13.42B 582B | P/E 2026 * |
-9.48x | P/E 2027 * | -9.49x |
|---|---|---|---|---|---|
| Enterprise Value | 2.93B 2.55B 2.37B 2.18B 4.12B 280B 4.18B 27.98B 10.98B 139B 11.02B 10.78B 467B | EV / Sales 2026 * |
86.4x | EV / Sales 2027 * | 28.4x |
| Free-Float |
90.08% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Denali Therapeutics Inc.
| 1 day | -5.46% | ||
| 1 week | -0.39% | ||
| 1 month | -10.50% | ||
| 3 months | +22.97% | ||
| 6 months | +5.89% | ||
| Current year | +39.43% |
| 1 week | 22.99 |  | 24.68 |
| 1 month | 22.01 | | 27.3 |
| Current year | 15.34 | | 27.3 |
| 1 year | 12.58 | | 27.3 |
| 3 years | 10.57 | | 33.33 |
| 5 years | 10.57 | | 56.8 |
| 10 years | 10.57 | | 93.94 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alexander Schuth
DFI | Director of Finance/CFO | 52 | 30/04/2022 |
Ryan Watts
CEO | Chief Executive Officer | 50 | 31/07/2015 |
Peter Chin
CTO | Chief Tech/Sci/R&D Officer | 58 | 05/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Ryan Watts
BRD | Director/Board Member | 50 | 28/02/2015 |
Jay Flatley
BRD | Director/Board Member | 73 | 31/03/2015 |
David Schenkein
BRD | Director/Board Member | 68 | 31/03/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03/06/26 | Free | Director | 25,634 | 0.0162% | ||
| 10/04/26 | Other | Chief Technology Officer | 204,402 | 0.1289% | ||
| 06/01/26 | Sell | Founder | 17,218 | 0.0110% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.46% | -0.39% | +66.45% | -19.03% | 3.65B | |
| +2.35% | +2.74% | +33.41% | +79.20% | 56.54B | |
| -0.21% | -7.38% | +25.34% | +63.02% | 53.6B | |
| -2.44% | +1.40% | -15.74% | -16.80% | 22.91B | |
| -2.85% | -7.78% | -8.09% | +346.36% | 21.37B | |
| +2.49% | -0.92% | +20.31% | -12.15% | 20.27B | |
| +0.79% | -1.06% | +29.29% | -33.32% | 17.56B | |
| +0.58% | -5.88% | +16.30% | +540.37% | 14.75B | |
| -5.25% | -4.23% | +46.41% | +169.05% | 13.33B | |
| +3.41% | -6.61% | +163.08% | +280.43% | 13.53B | |
| Average | -0.66% | -3.45% | +37.67% | +139.71% | 23.75B | |
| Weighted average by Cap. | +0.14% | -2.92% | +29.25% | +117.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 33.97M 29.53M 27.49M 25.24M 47.65M 3.24B 48.39M 324M 127M 1.61B 128M 125M 5.41B | 104M 90.11M 83.87M 77M 145M 9.89B 148M 989M 388M 4.93B 389M 381M 16.52B |
| Net income | -479M -416M -387M -356M -672M -45.7B -682M -4.57B -1.79B -22.75B -1.8B -1.76B -76.29B | -470M -409M -380M -349M -659M -44.86B -669M -4.48B -1.76B -22.33B -1.76B -1.73B -74.89B |
| Net Debt | -720M -626M -583M -535M -1.01B -68.73B -1.03B -6.87B -2.69B -34.22B -2.7B -2.64B -115B | -709M -616M -573M -526M -994M -67.64B -1.01B -6.76B -2.65B -33.67B -2.66B -2.6B -113B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | US$23.02 | -5.46% | 1,232,143 |
| 30/07/26 | US$24.35 | +2.10% | 1,117,649 |
| 29/07/26 | US$23.85 | -0.83% | 1,376,003 |
| 28/07/26 | US$24.05 | +2.04% | 2,106,287 |
| 27/07/26 | US$23.57 | +1.99% | 1,747,216 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DNLI Stock
Select your edition
All financial news and data tailored to specific country editions
